Expects Adjusted Profit attributable to Owners of the Parent in 2024 toGrowby Approximately 62% to 112% YoY

SHANGHAI,Feb. 17,2025--Nowadays,artificial intelligence (AI) technology is profoundly reshaping the landscape of the pharmaceutical and healthcare industry. As a global innovation-driven pharmaceutica

The Board of Directors of EQT AB ("EQT") has appointed Per Franzén as new CEO and Managing Partner,effective as of the Annual Shareholders\' Meeting on 27 May 2025. During this transi

NSFOCUS ISOP platform responds to emerging threats and evolving customer requirements,enhances operational efficiency,and allows for customization to meet diverse customer needs.

Leveraging multimodal AI to create high-quality product detail pages for e-commerce—completing texts,images,and layouts in 15–30 seconds

The accomplished global business executive will oversee the firm\'s strategic growth initiatives for the Asia-Pacific region.